Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acetaminophen
acetylcholine
acquired immunodeficiency syndrome
adverse drug reaction
airway obstruction
akathisia
alpha agonists
alpha methyltyrosine
analgesic
anticholinergic drugs
anticonvulsants
anticonvulsants, untoward effects of
antidepressant
antiemetic
antihistamines
anxiety
anxiolytic agents
aspirin
asterixis
athetosis
attention deficit disorder with hyperactivity
atypical
autonomic dysfunction
behavioral disorder
botulinum toxin
bromocriptine
buspirone
butyrophenone
CAT scan, abnormal
catatonia
cerebellar pontine angle
cerebellar pontine angle tumor
cerebrovascular accident
children
chlorpromazine
chorea
choreoathetosis
clonazepam
clonidine
cluster headache
codeine
compazine
complications
concerta
conversion reaction
coprolalia
cost effectiveness
creatine phosphokinase(CPK)elevated
deafness
deanol
degenerative diseases of CNS
depression
DHE
differential diagnosis
dilantin
dilantin, toxicity
diphenhydramine
domperidone
dopamine
dopamine agonist
dopamine antagonist
dopamine antagonist, peripheral
droperidol
drug induced neurologic disorders
dyskinesia
dyskinesia, buccal lingual facial
dyskinesia, drug induced
dystonia
dystonia, drug induced
dystonia, treatment of
dystonic reaction, acute
emergencies, neurologic
emergency room
epidemiology of neurology
ergotamine
excitotoxin
eye movement, disorders of
fever
Gilles de la Tourette syndrome
glutamic acid
guanfacine
haloperidol
headache
headache, emergency
headache, evaluation of
headache, prophylaxis
headache, treatment of
hearing loss
hemiballismus
hypertension
hyperthermia
iatrogenic neurologic disorders
impulsivity
L-dopa
leukocytosis
level of consciousness, decreased
lithium
lumbar puncture, indications for
mellaril
meperidine
metoclopramide
migraine
migraine, pregnancy
migraine, prophylaxis
migraine, treatment of
mimics
misdiagnosis
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, extrapyramidal-treatment of
movement disorder, post hemiplegic
movement disorder, treatment of
MRI
MRI, indications for
multiple sclerosis
muscle relaxant
myoclonus
narcotic analgesics
neoplasm, pituitary
neoplasm, pituitary, treatment of
neoplasm, primary of CNS-metastasizing to subarachnoid space
neurochemistry
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neurologic disease
neurologic disease, diagnoses of
neurologic testing
neurotoxin
neurotransmitter
NMDA antagonists
NMDA receptors
nonsteroidal anti-inflammatory drug
obsessive-compulsive disorder
oculogyric crisis
olanzapine
pain
pain, genital
papaverine
Parkinson disease
Parkinson disease, drug induced
Parkinson disease, exacerbation
Parkinson disease, treatment of
Parkinsonism syndrome
patient information and support
phenothiazine
physostigmine
pimozide
pituitary, adenoma
pituitary, adenoma, giant
practice guidelines
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
prolactin, elevated
prolactinoma
promethazine
propranolol
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
recurrent
renal failure
reserpine and reserpine like drugs
review article
rigidity
risk factors
sensorineural hearing loss
serotonin agonist
sinemet
steroid
steroid therapy, CNS treatment and complications with
stimulation, deep brain
sumatriptan
sweating
tardive akathisia
tardive dyskinesia
tardive dyskinesia, treatment of
tardive dystonia
tardive pain syndrome
tension headache
tetrabenazine
thiothixene
tic
tic, chronic multiple
tic, classification of
tic, motor
tic, recurrent
tic, sensory
tic, vocal
treatment of neurologic disorder
tremor
trifluoperazine
triptans
undiagnosed
Showing articles 150 to 200 of 1374 << Previous Next >>

Prospective Prevalence of Pathologic Gambling and Medication Association in Parkinson Disease
Neurol 66:1750-1752, Voon,V.,et al, 2006

Restless Legs Syndrome: Is Treatable But Under-Recognised
BMJ 333:457-458, Medcalf,P. &Bhatia,K.P., 2006

Efficacy and Safety of Pramipexole in Restless Legs Syndrome
Neurol 67:1034-1039, Winkelman,J.W.,et al, 2006

Efficacy of Cabergoline in Restless Legs Syndrome, A Placebo-Controlled Study with Polysomnography (CATOR)
Neurol 67:1040-1046, Oertel,W.H.,et al, 2006

Psychosis Related to Ropinirole
Am J Psychiatry 163:546-547, Perea,E.,et al, 2006

Survival after Treatment of Rabies with Induction of Coma
NEJM 352:2508-2514,2549, Willoughby,Jr.,R.E.,et al, 2005

Pleuropulmonary Fibrosis After Long-term Treatment With the Dopamine Agonist Pergolide for Parkinson Disease
Arch Neurol 62:1290-1295, Tintner,R.,et al, 2005

Sudden Uncontrollable Somnolence and Medication Use in Parkinson Disease
Arch Neurol 62:1242-1248, Avorn,J.,et al, 2005

Diagnosis and Initial Management of Parkinsons Disease
NEJM 353:1021-1027, Nutt,J.G.&Wooten,G.F., 2005

Pathological Gambling Caused by Drugs Used to Treat Parkinson Disease
Arch Neurol 62:1377-1381, Dodd,M.L.,et al, 2005

Cabergoline-Related Severe Restrictive Mitral Regurgitation
NEJM 353:1974-1975, Rosen,C.J., 2005

Effective Cabergoline Treatment in Idiopathic Restless Legs Syndrome
Neurol 63:2272-2279, Stiasny-Kolster,K.,et al, 2004

Treatment of Parkinson's Disease with Pergolide and Relation to Restrictive Valvular Heart Disease
Lancet 363:1179-1183, Van Camp,G.,et al, 2004

Memantine Treatment in Patients with Moderate to Severe Alzheimer Disease Already Receiving Donepezil, A Randomized Controlled Trial
JAMA 291:317-324, Tariot,P.N.,et al, 2004

Ropinirole in Gilles de la Tourette Syndrome
Neurol 62:1626-1627, Anea,M.H.,et al, 2004

Efficacy of Pergolide in Treatment of Restless Legs Syndrome
Neurol 62:1391-1397, Trenkwalder,C.,et al, 2004

Memantine in Moderate-to-Severe Alzheimer's Disease
NEJM 348:1333-1341, Reisberg,B.,et al, 2003

Heart Valvular Disease in Patients with Parkinson's Disease Treated with High-Dose Pergolide
Neurol 61:859-861, VanCamp,G.,et al, 2003

Prolactinoma
NEJM 349:2035-2041, Schlechte,J.A., 2003

Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
NEJM 349:2023-2033, Colao,A.,et al, 2003

A Controlled Trial of Rotigotine Monotherapy in Early Parkinson's Disease
Arch Neurol 60:1721-1728, The Parkinson Study Group, 2003

[123I]b-CIT SPECT is a Useful Method for Monitoring Dopaminergic Degeneration in Early Stage Parkinson's Disease
JNNP 74:294-298,287, Winogrodzka,A.,et al, 2003

Slowing Parkinson's Disease Progression
Neurol 60:381-389, Ahlskog,J.E., 2003

Initial Agonist Treatment of Parkinson Disease
Neurol 60:390-394, Albin,R.L. &Frey,K.A., 2003

Restless Legs Syndrome
NEJM 348:2103-2109, Earley,C.J., 2003

Pathological Gambling Associated with Dopamine Agonist Therapy in Parkinson's
Neurol 61:422-423, Driver-Dunckley,E.,et al, 2003

Tolerability of Memantine in Combination with Cholinesterase Inhibitors in Dementia Therapy
Int Clin Psychopharm 18:81-85, Hartmann,S.& Mobius, H.J., 2003

Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease
JAMA 287:455-463,509, Hobson,D.E.,et al, 2002

Alopecia Induced by Dopamine Agonists
Neurol 58:829-830, Tabamo,R.E. &Di Rocco,A., 2002

SUNCT Syndrome in Two Patient with Prolactinomas and Bromocriptine-Induced Attacks
Neurol 58:1698-1699, Massiou,H.,et al, 2002

Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease Progression
JAMA 287:1653-1661, Parkinson Study Group, 2002

A randomized,Double-blind,Placebo-Controlled Trial of Subcutaneously Injected Apomorphine for Parkinsonian Off-State Events
Arch Neurol 58:1385-1392, Dewey,R.B.,et al, 2001

Ten-year Follow-up of Three Different Initial Treatments in De-novo PD
Neurol 57:1687-1694, Lees,A.J.,et al, 2001

Acute Orhtostatic Hypotension When Starting Dopamine Agonists in Parkinson's Disease
Arch Neurol 57:1461-1463, Kujawa,K.,et al, 2000

Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
JAMA 284:1931-1938,1971, Parkinson Study Group, 2000

Dopamine Agonists: Their Role in the Treatment of Parkinson's Disease
JNNP 68;685-690, Brooks,D.J., 2000

Clinical Characteristics of Pramipexole-Induced Peripheral Edema
Arch Neurol 57:729-732, Tan,E.K.&Ondo,W., 2000

Safety of Pramipexole in Patients with Restless Legs Syndrome
Neurol 55:1589-1590, Stiasny,K.,et al, 2000

Tourette's Syndrome Improvement with Pergolide in a Randomized, Double-Blind, Crossover Trial
Neurol 54:1310-1315, Gilbert,D.L.,et al, 2000

A Five-Year Study of the Incidence of Dyskinesia in Patients With Early Parkinson's Disease who were Treated with Ropinirole or Levodopa
NEJM 342:1484-1491, Rascol,O.,et al, 2000

Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999

Falling Asleep at the Wheel:Motor Vehicle Mishaps in Persons Taking Pramipexole and Ropinirole
Neurol 52:1908-1910, Frucht,S.,et al, 1999

Restless Legs Syndrome Improved By Pramipecole, A Double-Blind Randomized Trial
Neurol 52:938-943, Montplaisir,J.,et al, 1999

A 3-Year Randomized Trial of Ropinirole and Bromocriptine in Early Parkinson's Disease
Neurol 53:364-370, Korczyn,A.D.,et al, 1999

Subcutaneous Apomorphine in Parkinson's Disease
Effective Yet Underused, BMJ 316:6411998., , 1998

Management of Pituitary Tumors
Ann Int Med 129:472-483, Shimon,I.&Melmed,S., 1998

Ropinirole for the Treatment of Early Parkinson Disease
Arch Neurol 55:1211-1216, Sethi,K.D.,et al, 1998

Randomized,Double-Blind,Placebo-Controlled Trial of Pergolide in Restless Leg Syndrome
Neurol 51:1599-1602, Earley,C.J.,et al, 1998

Encouraging Initial Response of Restless Legs Syndrome to Pramipexole
Neurol 51:1221-123, Becker,P.M.,et al, 1998

Permanent Cortical Damage Detected by Flumazenil Positron Emission Tomography in Acute Stroke
Stroke 29:454-461, Heiss,W.,et al, 1998



Showing articles 150 to 200 of 1374 << Previous Next >>